Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMass Spectrometry Imaging in Drug DevelopmentAnna Nilsson†, Richard J. A. Goodwin‡, Mohammadreza Shariatgorji†, Theodosia Vallianatou†, Peter J. H. Webborn‡, and Per E. Andrén*†View Author Information† Biomolecular Imaging and Proteomics, National Center for Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, P.O. Box 591 BMC, 75124 Uppsala, Sweden‡ Drug Safety & Metabolism, Innovative Medicines, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 OWG, U.K.*E-mail: [email protected]. Phone +46−18 471 7206. Mobile: +46−70 167 9334.Cite this: Anal. Chem. 2015, 87, 3, 1437–1455Publication Date (Web):December 19, 2014Publication History Published online14 January 2015Published inissue 3 February 2015https://doi.org/10.1021/ac504734sCopyright © 2014 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views4800Altmetric-Citations130LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (2 MB) Get e-AlertsSUBJECTS:Central nervous system,Ionization,Ions,Metabolism,Pharmaceuticals Get e-Alerts
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
